Family Firm, Inc. Eli Lilly & CO Transaction History

Family Firm, Inc.

$932 Million
Q3 2024

A detailed history of Family Firm, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Family Firm, Inc. holds 1,124 shares of LLY stock, worth $862,962. This represents 0.11% of its overall portfolio holdings.

Number of Shares

1,124

Previous 1,003 12.06%

Holding current value

$862,962

Previous $908,000 9.58%

% of portfolio

0.11%

Previous 0.1%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$772.14 - $960.02 $93,428 - $116,162	121 Added 12.06%	1,124 $995,000
Q2 2024 Jul 24, 2024	BUY	$724.87 - $909.04 $724 - $909	1 Added 0.1%	1,003 $908,000
Q1 2024 May 01, 2024	BUY	$592.2 - $792.28 $592 - $792	1 Added 0.1%	1,002 $779,000
Q4 2023 Feb 05, 2024	BUY	$525.19 - $619.13 $1,050 - $1,238	2 Added 0.2%	1,001 $583,000
Q3 2023 Oct 19, 2023	BUY	$434.7 - $599.3 $434 - $599	1 Added 0.1%	999 $536,000
Q2 2023 Aug 08, 2023	BUY	$350.74 - $468.98 $701 - $937	2 Added 0.2%	998 $468,000
Q1 2023 May 01, 2023	SELL	$310.63 - $364.82 $5,280 - $6,201	-17 Reduced 1.68%	996 $342,000
Q4 2022 Feb 07, 2023	BUY	$321.55 - $374.67 $643 - $749	2 Added 0.2%	1,013 $370,000
Q3 2022 Nov 15, 2022	BUY	$296.48 - $337.87 $2,075 - $2,365	7 Added 0.7%	1,011 $327,000
Q2 2022 Dec 01, 2022	SELL	$278.73 - $327.27 $557 - $654	-2 Reduced 0.2%	1,009 $327,000
Q1 2022 Nov 30, 2022	SELL	$234.69 - $291.66 $1,173 - $1,458	-5 Reduced 0.49%	1,006 $288,000
Q4 2021 Feb 02, 2022	BUY	$224.85 - $279.04 $674 - $837	3 Added 0.3%	1,004 $277,000
Q3 2021 Oct 22, 2021	BUY	$221.6 - $272.71 $443 - $545	2 Added 0.2%	1,001 $244,000
Q2 2021 Jul 21, 2021	BUY	$180.55 - $233.54 $180,369 - $233,306	999 New	999 $229,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Family Firm, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Family Firm, Inc. with notifications on news.

Account